
Manali Petrochem Q2 FY23 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 3
Margin
Category 2
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 3- India business is growing, with Notedome products holding close to 45% market share in certain high-margin categories and aiming to expand further.
- Penn Globe acquisition adds approximately GBP 16 million to top-line and is expected to sustain or improve EBITDA margins (~22%).
- Specialty chemical contribution targeted to grow from current 6% to around 20%.
- Indian agriculture and food segments expected to experience a CAGR of 12.3% over the next 5 years, driving demand for anti-foaming agents and related products.
- Capacity utilization for Penn Globe is high (85-90%) with plans to explore expansion based on new large customers, especially in the US.
- Manali Petrochemicals aims to expand PG (Propylene Glycol) production by 50,000 tons with Rs. 100 crore investment, projected to improve margins and volumes over 24 months post-clearances.
- Overall growth focus remains on both Indian and overseas markets, leveraging strong market potential in specialty chemicals.
See what Manali Petrochem management said on margin guidance — free account, 30 seconds.
Fundraise plans
- No specific new fundraising through debt or equity is mentioned in the transcript.
- Financing of the recent acquisition (Penn-White) was done entirely through Manali Petrochemicals Limited's (MPL) own funds.
- Refinancing of the working capital facility will be done with a new asset base lending system.
- Currently, MPL has no long-term debt on its books.
- Cash utilization will be evaluated in the future for expansions and overseas investments before deciding on any shareholder rewards.
- Focus remains on business growth and completing ongoing expansion projects before considering other financial actions.
See what Manali Petrochem management said on order book — free account, 30 seconds.
Capex plans
Yes- Rs. 100 crores approved for Propylene Glycol (PG) expansion of 50,000 tons. (Page 15)
- Focus on completing expansions in India with approvals in advanced stages; construction to start soon. (Page 14)
- Some cash set aside for overseas investments with potential for further opportunities. (Page 14)
- New subsidiary planned: Penn-White India Limited to manufacture specialty products domestically, leveraging lower costs and MPL's R&D. (Page 5)
- Expansion plans dependent on securing large customers, especially in the US; current capacity utilization at 85-90%. (Page 7)
- Emphasis on “Make in India” strategy to increase local manufacturing and reduce supply chain disruptions. (Page 9)
- Sustainability initiatives include developing a new carbon dioxide-based process that may replace fossil fuel raw materials, enhancing margins and environmental benefits upon commercial success. (Pages 15-16)
Track Manali Petrochem — get its next earnings analysis in your feed
How does Manali Petrochem rank vs peers in Chemicals & Petrochemicals?
Pro featureHow does Manali Petrochem rank in Chemicals & Petrochemicals?
Compare Manali Petrochem against every Chemicals & Petrochemicals company (Q2 FY23) on revenue, margins and earnings-call signals.
Continue your research
What Manali Petrochem's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Neogen Chemicals Ltd (Q2 FY27)
Consolidated: ₹295.96 crore (up from ₹208.66 crore in Q3 FY25) . Key results statement takeaways from Neogen Chemicals Ltd's Q2 FY27 results statement — and how
- Mahickra Chemicals Ltd (Q2 FY27)
682 million, a 34% year-on-year increase. Key results statement takeaways from Mahickra Chemicals Ltd's Q2 FY27 results statement — and how it ranks against sec
- Vishnu Chemicals Ltd (Q2 FY27)
2,837.7 lakhs increase (~7.07% growth YoY). Key results statement takeaways from Vishnu Chemicals Ltd's Q2 FY27 results statement — and how it ranks against sec
- Yasons Chemex (Q2 FY27)
4,927.35 lakhs for the same period in 2025, indicating a year-on-year decline of about 16.3% (Page 12). Key results statement takeaways from Yasons Chemex Care